MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term investments
$267,281K
Cash and cash
equivalents
$45,540K
Prepaid expenses and
other current assets
$20,076K
Total current assets
$332,897K
Other assets
$190K
Deferred offering costs
$69K
Right of use assets -
operating leases
$13K
Total assets
$333,169K
Total liabilities and
stockholders' equity
$333,169K
Total stockholders'
equity
$307,224K
Total liabilities
$25,945K
Accumulated deficit
-$404,641K
Additional paid-in capital
$711,847K
Total current
liabilities
$25,945K
Accumulated other
comprehensive income (loss)
$14K
Common stock 0.0001 par
value, 200,000,000...
$4K
Accrued expenses
$19,997K
Accounts payable
$5,934K
Operating lease
liabilities
$14K
Back
Back
Balance Sheet
source: myfinsight.com
ArriVent BioPharma, Inc. (AVBP)
ArriVent BioPharma, Inc. (AVBP)